048530.KQ
iNtRON Biotechnology, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 2,875.00
−5.58%Year over year
Reported trailing growth
- Revenue
- +40.9%
- EBITDA
- —
- EBIT
- -16.9%
- EPS
- -84.7%
- Free cash flow
- -14.2%
- Operating cash flow
- -40.6%
Forward estimates
Based on analyst estimates
- Revenue
- +347.3%
- EBITDA
- +177.0%
- EPS
- +128.8%
Three-year CAGR
- Revenue
- -25.7%
- EBITDA
- —
- EBIT
- -50.9%
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026